Summit Therapeutics to feature ivonescimab data at ESMO 2026
The company said the data will be presented in numerous presentations across multiple tumor types at the congress in Madrid, Spain.
GetSignal Summit Therapeutics Inc. SMMT
Summit Therapeutics said on October 22, 2026, that ivonescimab data will be featured in numerous presentations at the European Society for Medical Oncology 2026 Congress (ESMO 2026).
Key facts
- Event
- European Society for Medical Oncology 2026 Congress (ESMO 2026)
- Dates
- October 23 to 27, 2026
- Location
- Madrid, Spain
Source: The company's release on Business Wire, October 22, 2026.
Written by GetSignal with AI from the company's press release.
Not investment advice.
